Answers are grounded in this paper and cite their sources.
Biochemical analysis reveals selective cleavage of fibrinopeptides AP, AY, and A from human fibrinogen by Arvin, highlighting its distinct mechanism from other clotting enzymes.
Human fibrinogen was subjected to proteolysis by enzyme preparations (clinical Arvin and IRC-50 Arvin) from the venom of Agkistrodon rhodostoma. 2. IRC-50 Arvin releases three peptides from fibrinogen, and these were identified as fibrinopeptides AP, AY and A. 3. The less purified `clinical' Arvin releases, in addition to fibrinopeptides AP, AY and A, small amounts of two heptapeptides derived from fibrinopeptides AP and A, probably because it contains another enzyme as well as Arvin. 4. No fibrinopeptide B is released by either Arvin preparation. 5. Thus, although Arvin is known to differ from `reptilase' from Bothrops jararaca in that it does not activate the enzyme that cross-links fibrin (fibrin-stabilizing factor), it is identical with reptilase with respect to the peptides that it liberates from fibrinogen.
No takes yet. Share an insight, caveat, or question.
Ewart et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: